Loading: 100%
RadNet, Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 7,285 (as per Q2 2016)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker RDNTno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17036912
datesClosing price (adj.)
13.10.201711.25
11.10.201711.15
04.10.201711.50
27.09.201711.85
20.09.201710.85
13.09.201711.20
06.09.201711.10
30.08.201710.35
23.08.20179.40
16.08.20178.35
09.08.20177.95
02.08.20177.60
26.07.20177.80
19.07.20177.60
12.07.20177.55
05.07.20177.70
27.06.20177.50
20.06.20177.55
13.06.20177.80
06.06.20177.45
30.05.20177.25
23.05.20177.40
16.05.20177.10
09.05.20176.30
02.05.20176.10
25.04.20176.25
18.04.20175.95
11.04.20175.70
04.04.20175.50
28.03.20175.80
21.03.20175.75
14.03.20175.45
07.03.20175.70
28.02.20175.95
21.02.20176.20
14.02.20176.00
07.02.20175.83
31.01.20175.80
24.01.20176.00
17.01.20175.95
10.01.20176.50
03.01.20176.50
27.12.20166.80
19.12.20166.20
12.12.20166.20
05.12.20166.20
28.11.20166.10
21.11.20166.10
14.11.20166.60
07.11.20166.70
31.10.20166.95
24.10.20167.65
17.10.20167.49
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
11.25n/a
Market Capitalisation
in million USD
522n/a
Enterprise Value
in million USD
1,163n/a
Common Shares Outstanding
as per Jun 30, 2016
46,432,404n/a
Preferred Shares Outstanding
as per Jun 30, 2016
n/a
Average Basic Shares Outstanding
TTM
45,564,860n/a
Average Diluted Shares Outstanding
TTM
46,793,235n/a
Index Membership
n/a
Business Summary
RadNet Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, and among others.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 859n/a
Gross Profit 105n/a
Operating Income 41n/a
EBITDA 105n/a
Net Profit 11n/a
Balance Sheet
Cash and Cash Equivalents 0n/a
Receivables 165n/a
Total Current Assets 223n/a
PP&E 250n/a
Total Assets 828n/a
Accounts Payable 108n/a
Current Debt 29n/a
Total Current Liabilities 150n/a
Long-Term Debt 608n/a
Total Liabilities 791n/a
Total Equity 37n/a
Cash Flow
Depreciation & Amortisation 64n/a
Change in Working Capital -29n/a
Operating Cash Flow 91n/a
Net Change in PP&E and Intangibles -77n/a
Investing Cash Flow -77n/a
Dividends Paid 0n/a
Financing Cash Flow -18n/a
Total Change in Cash -5n/a
Free Cash Flow -10n/a
Profitability Ratios
Gross Margin 12.2%n/a
Operating Margin 4.8%n/a
Net Profit Margin 1.3%n/a
Return on Equity 31.1%n/a
Return on Assets 1.4%n/a
Per Share Figures
Basic EPS 0.24n/a
Diluted EPS 0.23n/a
Sales per Share 18.85n/a
Book Value per Share 0.73n/a
FCF per Share -0.22n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio 47.60n/a
Price to Sales Ratio 0.60n/a
Price to Book Value 13.87n/a
Price to Free Cash Flow -50.75n/a
Valuation Metrics
EV/EBITDA 11.12n/a
EV/Sales 1.35n/a
Book to Market Value 0.07n/a
Other Ratios
Current Ratio 148.3%n/a
Liabilities to Equity Ratio 2,140.8%n/a
Debt to Assets Ratio 76.9%n/a
Profit & Loss StatementP&L data quality: 63% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
528
519
585
647
703
718
810
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
-398
-421
-478
-543
-599
-603
-708
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
130
98
107
104
104
115
101
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-54
-54
-57
-58
-59
-59
-61
Selling, General & Administrative
0
0
0
0
0
0
0
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
0
0
0
0
0
0
0
Depreciation & Amortization
-54
-54
-57
-58
-59
-59
-61
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
76
44
50
46
45
56
41
Non-Operating Income (Loss)
-44
-44
-42
-44
-40
-36
-33
Interest Expense, net
-50
-48
-53
-54
-46
-43
-42
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
5
5
5
6
6
7
9
Other Non-Operating Income (Loss)
0
-1
5
4
0
0
0
Pretax Income (Loss), Adjusted
32
0
7
3
6
20
8
Abnormal Gains (Losses)
33
-12
1
2
0
-16
7
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
65
-12
8
4
6
4
15
Income Tax (Expense) Benefit, net
0
-1
-1
55
-4
-2
-6
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
64
-13
7
60
2
2
9
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
64
-13
7
60
2
2
9
Minority Interest
0
0
0
0
0
0
-1
Net Income
64
-13
7
60
2
1
8
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
64
-13
7
60
2
1
8
Remarks
restated on Mar 13, 2012 n/a
calculated values,
restated on Mar 18, 2013 n/a
calculated values,
restated on Mar 17, 2014 n/a
calculated values,
restated on Mar 16, 2015 n/a
calculated values,
restated on Mar 15, 2016 n/a
calculated values,
restated on Mar 15, 2016 n/a
calculated values,
restated on Mar 15, 2016 n/a
calculated values,
Balance SheetBS data quality: 91% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
1
2
2
0
0
0
Cash & Cash Equivalents
n/a
1
2
2
0
0
0
Short Term Investments
n/a
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
96
8
9
9
7
163
Accounts Receivable, Net
n/a
96
8
9
9
7
163
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
0
0
0
0
0
0
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
14
3
2
3
6
66
Prepaid Expenses
n/a
14
0
1
1
0
39
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
22
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
2
1
3
6
5
Total Current Assets
n/a
111
13
12
12
13
229
Property, Plant & Equipment, Net
n/a
194
22
19
18
14
257
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
234
9
11
11
10
350
Intangible Assets
n/a
0
0
0
0
0
0
Goodwill
n/a
143
8
10
10
10
239
Other Intangible Assets
n/a
57
1
1
1
0
45
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
25
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
15
0
0
0
0
34
Miscellaneous Long Term Assets
n/a
18
0
0
0
0
7
Total Noncurrent Assets
n/a
428
31
30
28
24
607
Total Assets
n/a
540
44
42
41
37
836
Liabilities and owners' equity
Payables & Accruals
n/a
83 82619000
4 3612000
2 2043000
2 1942000
1 1483000
114 113813000
Accounts Payable
n/a
83 82619000
4 3612000
2 2043000
2 1942000
1 1483000
114 113813000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Debt
n/a
17 17357000
3 2976000
1 1179000
1 835000
1 692000
32 32421000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
5 5288000
0 134000
0 167000
0 207000
0 231000
11 10725000
Deferred Revenue
n/a
2 2313000
0 134000
0 167000
0 207000
0 231000
4 4161000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
3 2975000
0 0
0 0
0 0
0 0
7 6564000
Total Current Liabilities
n/a
105 105264000
7 6722000
3 3389000
3 2984000
2 2406000
157 156959000
Long Term Debt
n/a
487 487217000
2 2330000
1 1150000
1 1257000
1 565000
606 606299000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
30 29506000
68 67947000
74 73534000
71 71423000
68 67521000
37 36708000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 277000
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
29 29229000
68 67947000
74 73534000
71 71423000
68 67521000
37 36708000
Total Noncurrent Liabilities
n/a
517 516723000
70 70277000
75 74684000
73 72680000
68 68086000
643 643007000
Total Liabilities
n/a
622 621987000
77 76999000
78 78073000
76 75664000
70 70492000
800 799966000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
162 162448000
0 0
0 0
0 0
0 0
197 197301000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-243 -242841000
0 0
0 0
0 0
0 0
-165 -164571000
Other Equity
n/a
-2 -2137000
0 0
0 0
0 0
0 0
0 -153000
Equity Before Minority Interest
n/a
-83 -82530000
0 0
0 0
0 0
0 0
33 32577000
Minority Interest
n/a
0 57000
0 0
0 0
0 0
0 0
4 3884000
Total Equity
n/a
-82 -82473000
0 0
0 0
0 0
0 0
36 36461000
Total Liabilities & Equity
n/a
540 539514000
77 76999000
78 78073000
76 75664000
70 70492000
836 836427000
Remarks restated on n/a restated on Mar 13, 2012 n/a restated on Nov 13, 2013 n/a restated on Mar 31, 2014 n/a restated on Mar 30, 2016 n/a restated on Mar 30, 2016 n/a restated on Aug 9, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-2
-13
7
60
2
2
9
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
54
54
57
58
59
59
61
Non-Cash Items
45
45
30
-22
38
56
47
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
-20
-20
-37
-20
-33
-56
-50
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
77
67
58
75
66
61
67
Change in Fixed Assets & Intangibles
-36
-101
-83
-86
-51
-50
-97
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
-5
-3
-2
-4
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
2
3
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
-36
-101
-88
-87
-51
-54
-97
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
-25
45
39
19
-8
-10
26
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
0
0
0
2
1
Increase in Capital Stock
0
0
0
0
0
2
1
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
-5
-20
-8
-10
0
-7
4
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
-30
25
32
10
-8
-15
30
Net Cash Before Disc. Operations and FX
10
-9
2
-2
8
-8
0
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
10
-9
2
-2
8
-8
0
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
10
-9
2
-2
8
-8
0
Remarks
restated on Mar 13, 2012 n/a
calculated values,
restated on Mar 18, 2013 n/a
calculated values,
restated on Mar 17, 2014 n/a
calculated values,
restated on Mar 16, 2015 n/a
calculated values,
restated on Mar 15, 2016 n/a
calculated values,
restated on Mar 15, 2016 n/a
calculated values,
restated on Mar 15, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo